Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can keeping blood pressure higher during surgery prevent organ damage?

NCT ID NCT04789733

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether keeping blood pressure higher than usual during and after major surgery can reduce serious complications like heart attack, kidney injury, and confusion. About 80 adults aged 45 and older who take blood pressure medication and are having long surgeries will be randomly assigned to either tight or routine blood pressure management. The goal is to see if this approach is feasible and safe before a larger trial.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
norepinephrine or phenylephrine (medicines to raise blood pressure)
What this could lead to
If it works, this could point toward a standard way to manage blood pressure during surgery to lower the risk of serious complications.
What could go wrong
This is a very small pilot study with only 80 people, so results may not apply widely. The tight control approach could also cause side effects like too-high blood pressure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2021

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ≥45 years old * Scheduled for major noncardiac surgery expected to last at least 2 hours; * Having general endotracheal, neuraxial anesthesia, or the combination; * Expected to require at least overnight hospitalization; * Are designated ASA physical status 2-4 (ranging from mild systemic disease through severe systemic disease that is a constant threat to life); * Chronically taking at least one anti-hypertensive medication; * Expected to have direct blood pressure monitoring with an arterial catheter; * Cared for by clinicians willing to follow the GUARDIAN protocol; * Subject to at least one of the following risk factors: * History of peripheral arterial surgery; * History of coronary artery disease; * History of stroke or transient ischemic attack; * Serum creatinine \>175 µmol/L (\>2.0 mg/dl); * Diabetes requiring medication; * Current smoking or 15 pack-year history of smoking tobacco; * Scheduled for major vascular surgery; * Body mass index ≥35 kg/m2; * Preoperative high-sensitivity troponin T \>14 ng/L or troponin I equivalent; * B-type natriuretic protein (BNP) \>80 ng/L or N-terminal B-type natriuretic protein (NT-ProBNP) \>100 ng/L Exclusion Criteria: * Are scheduled for carotid artery surgery; * Are scheduled for intracranial surgery; * Are scheduled for partial or complete nephrectomy; * Are scheduled for pheochromocytoma surgery; * Are scheduled for liver transplantation; * Require preoperative intravenous vasoactive medications; * Have a condition that precludes routine or tight blood pressure management such as surgeon request for relative hypotension; * Require beach-chair positioning; * Have end-stage renal disease requiring dialysis or estimated glomerular filtration rate (eGFR) \<30 ml/min; * Have a documented history of dementia; * Have language, vision, or hearing impairments that may compromise cognitive assessments; * Have contraindications to norepinephrine or phenylephrine per clinician judgement; * Have previously participated in this trial.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for General surgery are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • China Japan Union Hospital of Jilin University

    Changchun, Jilin, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.